Bio Forward Inc. (formerly Wisconsin Biotechnology and Medical Device Association Inc)

Registered Principal Details

Business Or Interest:
Trade association of Wisconsin biotechnology companies.

Lobbying Interests:
All human, plant and animal biotechnology issues such as stem cell research, cloning and drug therapy development.

CEO Name:
Lisa Johnson
Attorney

Contact
JL
Jordan Lamb
214 N. Hamilton St., Suite 202
Madison, WI 53703
(608) 252-9358
jkl@dewittross.com
http://www.wisbiomed.org

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Legislative Bills/Resolutions

August 2017 Special Session Assembly Bill 1
August 2017 Special Session Assembly Bill 1
Relating to: authorizing the creation of an electronics and information technology manufacturing zone, making changes to the enterprise zone tax credit program, authorizing limited use of the design-build construction process, granting contingent highway b...

Bill Text and History

2017 Wisconsin Act 58

For
Notification Date
8/2/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 69
Assembly Bill 69
Relating to: access to investigational drugs, devices, and biological products and limitations on liability related to their use.

Bill Text and History

Other
Notification Date
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Comments
BioForward is neutral on this bill provided participation by manufacturers is voluntary and liability protections are provided.
Assembly Bill 277
Assembly Bill 277
Relating to: eliminating the personal property tax and making an appropriation. (FE)

Bill Text and History

For
Notification Date
5/23/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 549
Assembly Bill 549
Relating to: use and final disposition of fetal body parts and providing a penalty.

Bill Text and History

Against
Notification Date
1/12/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 640
Assembly Bill 640
Relating to: creating the innovation fund and economic development programs funded by that fund, establishing the Innovation Fund Council, authorizing the State of Wisconsin Investment Board to provide certain advice and services to state agencies and othe...

Bill Text and History

For
Notification Date
11/15/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 679
Assembly Bill 679
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.

Bill Text and History

For
Notification Date
12/11/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 758
Assembly Bill 758
Relating to: University of Wisconsin research contracts. (FE)

Bill Text and History

For
Notification Date
1/2/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 84
Senate Bill 84
Relating to: access to investigational drugs, devices, and biological products and limitations on liability related to their use.

Bill Text and History

2017 Wisconsin Act 165

Other
Notification Date
8/14/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Comments
BioForward is neutral on this bill provided participation by manufacturers is voluntary and liability protections are provided.
Senate Bill 218
Senate Bill 218
Relating to: eliminating the personal property tax and making an appropriation. (FE)

Bill Text and History

For
Notification Date
5/23/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 422
Senate Bill 422
Relating to: sale of and research on fetal body parts, final disposition of fetal body parts, cord blood banks, and providing a criminal penalty.

Bill Text and History

Other
Notification Date
10/5/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 423
Senate Bill 423
Relating to: use and final disposition of fetal body parts and providing a penalty.

Bill Text and History

Against
Notification Date
10/5/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 525
Senate Bill 525
Relating to: creating the innovation fund and economic development programs funded by that fund, establishing the Innovation Fund Council, authorizing the State of Wisconsin Investment Board to provide certain advice and services to state agencies and othe...

Bill Text and History

For
Notification Date
11/15/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 575
Senate Bill 575
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.

Bill Text and History

2017 Wisconsin Act 149

For
Notification Date
11/21/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 671
Senate Bill 671
Relating to: University of Wisconsin research contracts. (FE)

Bill Text and History

For
Notification Date
1/8/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Budget Bill Subjects

General Provisions
Biennial budget bill treatment of matter relating to
General Provisions

Notification Date
3/13/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

University of Wisconsin System
Biennial budget bill treatment of matter relating to
University of Wisconsin System

Notification Date
3/13/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

2019-21 State Budget Bill
Development, drafting or introduction of a proposal relating to
2019-21 State Budget Bill

Action Intended To Affect
Both Legislative matter and rule

Notification Date
5/10/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Substitution of interchangeable biosimilars
Development, drafting or introduction of a proposal relating to
Substitution of interchangeable biosimilars

Action Intended To Affect
Both Legislative matter and rule

Notification Date
7/20/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

LRB-1927/1: Sale of and research on fetal body parts, final disposition of fetal body parts, cord blood banks, and providing a criminal penalty
Development, drafting or introduction of a proposal relating to
LRB-1927/1: Sale of and research on fetal body parts, final disposition of fetal body parts, cord blood banks, and providing a criminal penalty

Action Intended To Affect
Both Legislative matter and rule

Notification Date
2/8/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

The development of legislation regarding innovation
Development, drafting or introduction of a proposal relating to
The development of legislation regarding innovation

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/4/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Legislation prohibiting certain types of research
Development, drafting or introduction of a proposal relating to
Legislation prohibiting certain types of research

Action Intended To Affect
Both Legislative matter and rule

Notification Date
12/20/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

2017-19 State Budget Bill
Development, drafting or introduction of a proposal relating to
2017-19 State Budget Bill

Action Intended To Affect
Both Legislative matter and rule

Notification Date
12/20/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
Total Lobbying Expenditures 2017
January - June
$31,284.93
2017
July - December
$36,920.19
2018
January - June
$17,553.44
2018
July - December
$12,380.49
Total $98,139.05
Total Hours Communicating 2017
January - June
26.70
2017
July - December
34.15
2018
January - June
11.10
2018
July - December
5.35
Total 77.30
Total Hours Other 2017
January - June
94.15
2017
July - December
151.75
2018
January - June
54.30
2018
July - December
28.70
Total 328.90

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: access to investigational drugs, devices, and biological products and limitations on liability related to their use.
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
5%
2017
July - December
3%
2018
January - June
2018
July - December
Total 3%
Relating to: eliminating the personal property tax and making an appropriation. (FE)
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
5%
2017
July - December
2018
January - June
2018
July - December
Total 1%
Relating to: eliminating the personal property tax and making an appropriation. (FE)
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
5%
2017
July - December
2018
January - June
2018
July - December
Total 1%
Relating to: access to investigational drugs, devices, and biological products and limitations on liability related to their use.
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
2%
2018
January - June
2018
July - December
Total < 1%
Relating to: creating the innovation fund and economic development programs funded by that fund, establishing the Innovation Fund Council, authorizing the State of Wisconsin Investment Board to provide certain advice and services to state agencies and others, and making appropriations. (FE)
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
10%
2018
January - June
15%
2018
July - December
Total 7%
Relating to: sale of and research on fetal body parts, final disposition of fetal body parts, cord blood banks, and providing a criminal penalty.
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
10%
2018
January - June
2018
July - December
Total 5%
Relating to: creating the innovation fund and economic development programs funded by that fund, establishing the Innovation Fund Council, authorizing the State of Wisconsin Investment Board to provide certain advice and services to state agencies and others, and making appropriations. (FE)
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
10%
2018
January - June
15%
2018
July - December
Total 7%
Relating to: use and final disposition of fetal body parts and providing a penalty.
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
15%
2018
January - June
2018
July - December
Total 7%
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
20%
2018
January - June
20%
2018
July - December
Total 12%
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
30%
2018
January - June
20%
2018
July - December
Total 17%
Relating to: University of Wisconsin research contracts. (FE)
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
2018
January - June
10%
2018
July - December
Total 2%
Relating to: University of Wisconsin research contracts. (FE)
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
2018
January - June
10%
2018
July - December
Total 2%

Budget Bill Subjects

2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
10%
2017
July - December
2018
January - June
2018
July - December
Total 3%
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
25%
2017
July - December
2018
January - June
2018
July - December
Total 7%

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
25%
2017
July - December
2018
January - June
2018
July - December
Total 7%
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
25%
2017
July - December
2018
January - June
2018
July - December
Total 7%
2017
January - June
2017
July - December
2018
January - June
2018
July - December
Total
2017
January - June
2017
July - December
2018
January - June
10%
2018
July - December
100%
Total 10%

Minor Efforts

No minor efforts found.

Other Matters

No other matters found.

Filed Statements of Lobbying Activity and Expenditures